concept

AMYLOID BURDEN

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AMYLOID BURDEN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

29Connections

1Hypotheses

9Analyses

9Outgoing

20Incoming

0Experiments

20Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	AMYLOID BURDEN

Pathway Diagram

graph TD
    AMYLOID_BURDEN[AMYLOID BURDEN]
    AMYLOID_BURDEN -.biomarker for.-> Alzheimer_s_Disease[Alzheimer's Disease]
    AMYLOID_BURDEN -->|downregulates| cognitive_function[cognitive function]
    AMYLOID_BURDEN -->|correlates_with| Cholinergic_Integrity[Cholinergic Integrity]
    AMYLOID_BURDEN -->|downregulates| cholinergic_white_matter_integ[cholinergic white matter integrity]
    brain_penetrant_recombinant_an[brain-penetrant recombinant antibody] -->|decreases| AMYLOID_BURDEN
    Brain_Penetrant_Complement_Blo[Brain-Penetrant Complement-Blocking Antibody] -->|downregulates| AMYLOID_BURDEN
    Dazucorilant[Dazucorilant] -->|targets| AMYLOID_BURDEN
    APOE[APOE] -->|modulates| AMYLOID_BURDEN
    APOE4[APOE4] -->|modulates| AMYLOID_BURDEN

Outgoing (9)

Target	Relation	Type	Str
Alzheimer's Disease	biomarker_for	disease	0.90
Cognitive Performance	associated_with	phenotype	0.90
Cholinergic Integrity	correlates_with	biomarker	0.85
cognitive function	downregulates	phenotype	0.85
cholinergic white matter integrity	downregulates	phenotype	0.80
Mini-Mental Status Examination	associated_with	phenotype	0.80
Cognitive decline	associated_with	phenotype	0.70
hippocampal-cortical connectivity disruption	causes	process	0.70
Cognitive decline	biomarker_for	phenotype	0.50

Incoming (20)

Source	Relation	Type	Str
brain-penetrant recombinant antibody	decreases	compound	0.90
Complement-Blocking Antibody	associated_with	drug	0.90
34499614	reduced	paper	0.90
Microglial TFEB Overexpression	associated_with	mechanism	0.90
APOE	modulates	gene	0.85
Brain-Penetrant Complement-Blocking Antibody	downregulates	drug	0.85
Dazucorilant	targets	drug	0.85
APOE	modulates	gene	0.85
APOE4	modulates	protein	0.80
Orexin-A	biomarker_for	biomarker	0.70
CSF orexin-A	associated_with	biomarker	0.70
Trem2 Haploinsufficiency	regulates	phenotype	0.70
ABCA1	regulates	gene	0.70
SNTA1 deletion	causes	gene	0.70
TREM2 expression	biomarker_for	process	0.70
APOE	regulates	protein	0.70
40Hz gamma entrainment	reduces	process	0.70
IL-33 administration	reduces	drug	0.70
TREM2 agonism	prevents	process	0.70
29563219	can reduce	paper	0.60

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
APOE4-microglial complement signaling causes cholinergic-enr	0.630	neurodegeneration	What determines the temporal sequence of

Mentioning Analyses (9)

Scientific analyses that reference this entity

Test Preregistration Analysis

neurodegeneration | 2026-04-27 | 7 hypotheses Top: 0.710

Neuroinflammation Biomarker Panel for Early AD Detection

neurodegeneration | 2026-04-18 | 7 hypotheses Top: 0.105

Analyze the spectrum of microglial activation states (DAM, homeostatic, inflamma

neurodegeneration | 2026-04-17 | 0 hypotheses

What is the temporal sequence of sleep disruption versus amyloid-beta accumulati

neurodegeneration | 2026-04-12 | 0 hypotheses

Which specific aging-related gene expression changes in mouse brain predict huma

neurodegeneration | 2026-04-11 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (20)

Multi-agent debates referencing this entity

Test question for preregistration

active · Rounds: 4 · Score: 0.77 · 2026-04-28

Extended debate: Closed-loop transcranial focused ultrasound with 40Hz gamma ent

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Extended debate: Closed-loop tACS targeting EC-II SST interneurons to block tau

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound targeting entorhinal PV inte

closed · Rounds: 4 · Score: 0.65 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II SST interneurons to block tau propagati

closed · Rounds: 4 · Score: 0.71 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound to restore hippocampal gamma

closed · Rounds: 4 · Score: 0.87 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II PV interneurons to suppress burst firin

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II somatostatin interneurons to restore de

closed · Rounds: 4 · Score: 0.54 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound with real-time gamma feedbac

closed · Rounds: 4 · Score: 0.19 · 2026-04-27

Hypothesis debate: Closed-loop transcranial alternating current stimulation to r

closed · Rounds: 4 · Score: 0.40 · 2026-04-27

Related Research

Hypotheses and analyses mentioning AMYLOID BURDEN in their description or question text

No additional research found